- Corporate Officers - P
- Pearson Timothy R
Insider Trading History of Pearson Timothy R
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pearson Timothy R since 2017.
This trader's CIK number is 1528617.
At the time of last reporting, Pearson Timothy R was the Director of Glycomimetics Inc. (stock ticker symbol GLYC).
Also see all insider trading activities at Glycomimetics Inc.
Note that in the past
PEARSON TIMOTHY R also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Glycomimetics Inc (GLYC) by Pearson Timothy R
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | GLYC | 19,400 | $25,026 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tesaro, Inc. (TSRO) by Pearson Timothy R
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | TSRO | 0 | $0 | 2,575 | $141,264 | 5,858 | $0 |
2017 | TSRO | 0 | $0 | 1,447 | $257,001 | 4,375 | $0 |
Insider trading activities at 2 companies by Pearson Timothy R:
1. Glycomimetics Inc (GLYC)
2. Tesaro, Inc. (TSRO)
Table 1. Insider trading of Glycomimetics Inc (GLYC) by Pearson Timothy R
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-11-11 | GLYC | Buy | 19,400 | 1.29 | 25,026 |
Table 2. Insider trading of Tesaro, Inc. (TSRO) by Pearson Timothy R
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-03-02 | TSRO | Sale | 2,575 | 54.86 | 141,264 |
2018-03-01 | TSRO | Option Ex | 5,858 | .00 | 0 |
2017-03-02 | TSRO | Sale | 1,447 | 177.61 | 257,001 |
2017-03-01 | TSRO | Option Ex | 4,375 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Pearson Timothy R
(Director of Glycomimetics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.